SEQONE GENOMICS
Healthcare is undergoing a revolution, known as genomic medicine, that uses the patient’s genomic information to optimise treatment. This trend is accelerating thanks to the arrival of New Generation Sequencing (NGS) techniques that have reduced the cost of decoding genomic material while increasing the amount useful data obtained. However, NGS has had only limited impact on mainstream healthcare due to the difficulties in analyzing more and richer genomic data. SeqOne’s mission is to provide tools that enable the healthcare industry to analyse NGS genomic data better and more cost-effectively to provide universal access to genomic medicine.
SEQONE GENOMICS
Industry:
Big Data Biotechnology Health Care
Founded:
2017-01-01
Address:
Montpellier, Languedoc-Roussillon, France
Country:
France
Website Url:
http://www.seqone.com
Total Employee:
11+
Status:
Active
Contact:
+33 6 03 24 57 56
Total Funding:
23 M EUR
Technology used in webpage:
Organization Schema PHP 7 Smart App Banner OVH Accelerated Mobile Pages
Similar Organizations
HealthVerity
HealthVerity powers the discovery, licensing, and linkage of traditional and emerging healthcare data.
Current Employees Featured
Jean-Marc Holder COO @ SeqOne Genomics
COO
2017-05-01
Guillaume Buwalda CTO @ SeqOne Genomics
CTO
2017-03-01
Nicolas Philippe CEO @ SeqOne Genomics
CEO
2017-03-01
Founder
Investors List
Software Club
Software Club investment in Series A - SeqOne Genomics
Merieux Developpement
Merieux Developpement investment in Series A - SeqOne Genomics
Elaia
Elaia investment in Series A - SeqOne Genomics
Omnes Capital
Omnes Capital investment in Series A - SeqOne Genomics
IRDI
IRDI investment in Series A - SeqOne Genomics
IRDI SORIDEC Gestion
IRDI SORIDEC Gestion investment in Seed Round - SeqOne Genomics
Bpifrance
Bpifrance investment in Seed Round - SeqOne Genomics
Elaia
Elaia investment in Seed Round - SeqOne Genomics
Official Site Inspections
http://www.seqone.com Semrush global rank: 4.14 M Semrush visits lastest month: 2.89 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "SeqOne Genomics"
Home - SeqOne
The vision uniting the SeqOne team is a desire to improve patient outcomes with improved genomic analysis.We use significant resources on research and development to ensure that …See details»
Who we are - SeqOne
The mission. The mission we have set ourselves is to build an ecosystem that combines experts from SeqOne, the industry and academia, in order to deliver the most effective, easy-to-use genomic analysis solutions by following these …See details»
SeqOne Genomics - Crunchbase Company Profile
SeqOne Platform: A cloud-based clinical informatics platform designed for bioinformatics analysis of raw high-throughput sequencing data to assist in …See details»
SeqOne - EuroQuity
About your organization / profile Genomic medicine, an approach that adapts medical treatment to a patient’s genetic makeup, has been made possible thanks to the emergence of New Generation Sequencing (NGS) technologies. ...See details»
SeqOne Genomics - Leadership Team - The Org
The Leadership Team at SeqOne Genomics is responsible for steering the strategic direction of the company, overseeing financial health, guiding marketing efforts, driving engineering …See details»
SeqOne - 2025 Company Profile, Funding & Competitors - Tracxn
Mar 6, 2025 Michael Blum joins SeqOne Genomics to Head the Company’s Research and DevelopmentBusiness Wire • Oct 20, 2022 • SeqOne AI-driven platform for genomic experts …See details»
Resource center - SeqOne
SeqOne Platform is an in vitro diagnostic medical device, CE-IVD certified, designed to perform bioinformatics analysis of raw high-throughput sequencing data to help diagnosis. …See details»
SeqOne – Elaia
Apr 3, 2019 SeqOne announces a three million euro funding round led by Elaia with IRDI / SORIDEC and supported by BPI France. The funding will accelerate the development of SeqOne’s genetic analysis platform combining AI and big …See details»
SeqOne Genomics - Crunchbase
SeqOne is a next generation genomic analysis for next generation healthcare.See details»
Chinese biotech firm MGI Tech partners with French startup …
Jun 19, 2024 "By combining MGI's state-of-the-art sequencing technology with SeqOne's innovative genome analysis platform, we are able to deliver real insights and solutions for …See details»
SeqOne achieves IVDR certification as a Class C device
Nov 14, 2024 SeqOne Genomics is a leading provider of genomic data analysis solutions, offering fast, accurate, and scalable genomic analysis for healthcare providers. With a specialized focus on oncology and rare diseases, SeqOne’s …See details»
GeniOS™ genomics operating system SeqOne SAS (SeqOne …
SeqOne SAS. (1/24/22). "Press Release: SeqOne Genomics Closes €20M Series A to Accelerate the Deployment of Its Genomic Medicine Platform". Montpellier. The funding will drive …See details»
Une PME française, leader de la génomique personnalisée
Jan 24, 2022 La société SeqOne Genomics, une entreprise montpelliéraine, annonce avoir levé 20 millions d’euros.Son ambition : devenir « le leader mondial de la médecine génomique …See details»
Genome Alert!
Genome Alert! is a collaboration of the Université Grenoble Alpes, SeqOne and CHU de Rouen. Legal notice (under French law) are available here. ClinVar mendelian genome. Download …See details»
New whole genome nanopore sequencing partnership targeting …
Mar 12, 2024 Oxford Nanopore Technologies and AI-driven genomic decision support software company SeqOne have announced a new partnership, which will enable end-to-end analytical …See details»
MGI Tech and SeqOne Partner to Advance End-to-End Genomic …
Jun 17, 2024 SeqOne is a fast-growing deep-tech company focused on turning genomic data into medically- actionable insights in oncology and rare and inherited diseases. Our vision is to …See details»
La deeptech SeqOne lève 20 millions d'euros pour accélérer dans …
Jan 24, 2022 Créatrice d’une plateforme d’analyse génomique de nouvelle génération, la société montpelliéraine SeqOne Genomics (42 salariés) boucle une levée de fonds de 20 millions …See details»
Challenging variants in constitutional diseases - SeqOne
SeqOne S.A.S. 22 rue Durand 34000 Montpellier, France. SeqOne Platform is an in vitro diagnostic medical device, CE-IVD certified, designed to perform bioinformatics analysis of …See details»
PRESS RELEASE SeqOne raises 3 million euros to accelerate the
About SeqOne . SeqOne develops state-of-the-art genomics analysis tools for clinical applications in the fields of cancer and rare disease. Its flagship product, SeqOne | Platform is a cloud …See details»
CHU de Reims is Transforming Patient Care with SeqOne
Dec 5, 2024 The SeqOne platform has evolved significantly since 2018. Throughout these changes, our experience with SeqOne’s customer support and the implementation process …See details»